ACE and non-small cell lung carcinoma: RASBs renin-angiotensin system blockers; ACEIs angiotensin-converting enzyme inhibitors; ARBs angiotensin-2 receptor 1 blockers; SD standard deviation; NSCLC non-small cell lung cancer; SCLC small cell lung cancer.